Massive study looks at benefits, risks of GLP-1 weight-loss drugs

by

NEW YORK, Jan. 22 (UPI) — As demand for weight-loss injections sold under brand names such as Ozempic and Wegovy continues to soar, a new study has uncovered neurological and … Click to Continue »

View original article
Contributor: